In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Transmedics Group Inc (NASDAQ: TMDX) closed at $127.28 in the last session, down -4.05% from day before closing price of $132.65. In other words, the price has decreased by -$4.05 from its previous closing price. On the day, 0.92 million shares were traded. TMDX stock price reached its highest trading level at $132.96 during the session, while it also had its lowest trading level at $125.86.
Ratios:
We take a closer look at TMDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.76 and its Current Ratio is at 9.72. In the meantime, Its Debt-to-Equity ratio is 3.24 whereas as Long-Term Debt/Eq ratio is at 3.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $95.
JP Morgan Upgraded its Neutral to Overweight on August 02, 2022, while the target price for the stock was maintained at $48.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 03 ’24 when TOBIN JAMES R sold 12,025 shares for $125.05 per share. The transaction valued at 1,503,686 led to the insider holds 193,146 shares of the business.
Hassanein Waleed H sold 12,444 shares of TMDX for $1,510,868 on May 02 ’24. The President & CEO now owns 61,643 shares after completing the transaction at $121.41 per share. On May 01 ’24, another insider, Khayal Tamer I, who serves as the Chief Commercial Officer of the company, sold 63,260 shares for $108.54 each. As a result, the insider received 6,866,360 and left with 9,792 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMDX now has a Market Capitalization of 4192259584 and an Enterprise Value of 4358264832. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.12 while its Price-to-Book (P/B) ratio in mrq is 26.22. Its current Enterprise Value per Revenue stands at 14.678 whereas that against EBITDA is 166.429.
Stock Price History:
Over the past 52 weeks, TMDX has reached a high of $132.85, while it has fallen to a 52-week low of $36.42. The 50-Day Moving Average of the stock is 46.79%, while the 200-Day Moving Average is calculated to be 73.72%.
Shares Statistics:
According to the various share statistics, TMDX traded on average about 897.50K shares per day over the past 3-months and 1367070 shares per day over the past 10 days. A total of 32.67M shares are outstanding, with a floating share count of 31.72M. Insiders hold about 3.70% of the company’s shares, while institutions hold 109.37% stake in the company. Shares short for TMDX as of 1713139200 were 6325086 with a Short Ratio of 7.05, compared to 1710460800 on 5407671. Therefore, it implies a Short% of Shares Outstanding of 6325086 and a Short% of Float of 23.53.
